Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma.
Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma. Oncotarget. 2019 Mar 22; 10(24):2369-2383.